Advertisement
Home »

Probiotic Enhances Clinical Outcomes in Metastatic RCC

Jun 08, 2023

REFERENCES & ADDITIONAL READING

Choueiri TK, et al. N Engl J Med. 2021;384:829-841.

Dizman N, et al. Nature Med. 2022;28:704-712.

Ebrahimi H, et al. Effect of CBM588 in combination with cabozantinib plus nivolumab for patients with metastatic renal cell carcinoma (mRCC): a randomized clinical trial. Abstract LBA104. ASCO Annual Meeting 2023, 2–6 June, Chicago.

Tomita Y, et al. Cancer Immunol Res. 2020;8:1236-1242.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement